Active not recruitingNAINTERVENTIONAL

HIV Patients Cohort

This study wants to learn more about people living with HIV in the UK, whether they are on treatment or not. In recent years, HIV has become a long-term condition, much like diabetes or heart disease, with people living longer thanks to new medicines. However, these medicines can have side effects, and living longer with HIV can bring new health challenges. By gathering information and blood samples from volunteers, researchers hope to better understand these challenges. This information will help doctors choose the best treatments and care plans, aiming to improve the health and well-being of everyone living with HIV.

At a glance

Status

Active not recruiting

Phase

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrolment target

1,613

Start

19 Oct 2011

Estimated completion

19 Nov 2030

Patients Affected by the HIV

What is this study about?

This research study is all about improving our understanding of HIV. For a long time, HIV was a very serious illness. But thanks to powerful new medications, called 'tritherapies', HIV has become a condition that people can live with for many years. This means it's now often seen as a long-term health issue, similar to other conditions like diabetes, where ongoing care is key. However, living with HIV for a long time and taking medication can bring new health challenges, such as risks to your heart or changes to your body's metabolism.

The main goal of this study is to gather as much information as possible about people living with HIV – both those who are taking treatment and those who aren't. By doing this, researchers hope to better understand these challenges and how HIV affects people over many years. This understanding is vital for doctors and nurses to provide the best possible care, making sure people with HIV stay as healthy as possible and can spot any potential problems early.

Imagine this study as building a detailed picture of HIV in the UK. Researchers will collect information and blood samples over time. This will help them look for patterns, understand how different treatments work, and even explore how a person's genes might play a role in their health with HIV. Ultimately, all this work is aimed at finding the very best ways to treat and care for people living with HIV, helping them lead full and healthy lives.

Key takeaways

This study collects vital information on people living with HIV.
It aims to improve future care and treatment for HIV.
Participation involves regular check-ups and blood samples over many years.
The study observes current care and does not test new medications.
Your data will help understand long-term effects of HIV and treatments.
You can stop participating at any time.

Who may be eligible?

To take part in this study, you need to meet a few simple criteria. First, you must be at least 18 years old. This study is for adults, so unfortunately, younger individuals cannot join.

Secondly, you must be diagnosed with HIV. The study is specifically looking at people who are currently living with the HIV virus, whether they are receiving treatment or not.

Finally, you need to be willing to give your 'informed consent'. This means you’ll have all the information about the study explained to you clearly, and you’ll understand what's involved before you agree, in writing, to participate. Your decision will be entirely yours.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Have you been diagnosed with HIV?
Are you able to understand the study information and give written permission to take part?

Answer every question to see your result.

What does participation involve?

This study is mainly about collecting information and samples over time. If you decide to take part, you would be joining a group of people living with HIV who are being carefully monitored. This would involve regular check-ups where doctors would record details about your health and treatment. You would also be asked to provide blood samples during these visits.

The study does not involve taking new or experimental medications. Instead, it focuses on understanding how HIV and current treatments affect people in the real world. The total duration of your participation would be over many years, allowing researchers to track your health and changes over a long period. This long-term approach helps them see the bigger picture of living with HIV.

Potential risks and benefits

Taking part in this study won't offer a direct, immediate medical benefit to you personally, as it's observational and focused on gathering information. However, the information collected will greatly help doctors and researchers understand HIV better, potentially leading to improved care and treatment for everyone with HIV in the future. The risks of participating are generally low; they mainly involve the usual discomfort and very small risk of bruising or infection from blood tests. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

Hôpital Hôtel Dieu
Verified postcode
Paris, France

Common questions

What is the main goal of this study?

The main goal is to improve our understanding of HIV and find better ways to care for people living with it.

Do I need to be on HIV treatment to join?

No, the study includes people with HIV who are both on treatment and not on treatment.

Will I have to take new medicine in this study?

No, this study is about observing current care and how HIV affects people; it doesn't involve new medicines.

What will happen if I join the study?

You'll have regular check-ups and give blood samples over several years to help researchers learn more.

Can I leave the study if I change my mind?

Yes, you are free to leave the study at any time without it affecting your usual medical care.